Generate raises $273M—$100M less than previous round—but a huge bounty

[cafead]

via Flagship Pioneering-founded Generate Biomedicines is tacking on a gigantic $273 million in series C funds, though the haul didn't reach the heights of the biotech’s previous $370 million raise back in 2021.

article source